Translational approaches to obsessive-compulsive disorder: From animal models to clinical treatment

British Journal of Pharmacology

Volumn 164, Issue 4, 2011, Pages 1044-1061

  Fineberg, Na ^a,b,c   Chamberlain, Sr ^c,d   Hollander, E ^f   Boulougouris, V ^g   Robbins, Tw ^d,e  

^a HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UK   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

compulsivity; dopamine; flexibility; impulsivity; inhibition; OCD; serotonin; translational

Indexed keywords

ACETYLCYSTEINE; AGOMELATINE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; FLUVOXAMINE; MEMANTINE; METHYLPHENIDATE; MONOAMINE; MOOD STABILIZER; PLACEBO; QUINPIROLE; RILUZOLE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL MODEL; ANXIETY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTRUCT VALIDITY; CORPUS STRIATUM; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MODEL; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG RESEARCH; FACE VALIDITY; FRONTAL CORTEX; FUNCTIONAL DISEASE; GENETIC MODEL; HUMAN; LEARNING; LOW DRUG DOSE; MOTOR PERFORMANCE; NEUROBIOLOGY; NEUROMODULATION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PARTHENOGENESIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SYMPTOMATOLOGY; TREATMENT RESPONSE; TRICHOTILLOMANIA; VALIDATION STUDY;

ANIMALS; ANXIETY DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; REPRODUCIBILITY OF RESULTS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 80053331478     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01422.x     Document Type: Review

References (209)

1. Abbruzzese M, Ferri S, Scarone S, (1997). The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia 35: 907-912. (Pubitemid 27263234)
2. Aldridge JW, Berridge KC, (1998). Coding of serial order by neostriatal neurons: a 'natural action' approach to movement sequence. J Neurosci 18: 2777-2787.
3. Altemus M, Glowa JR, Galliven E, Leong YM, Murphy DL, (1996). Effects of serotonergic agents on food-restriction-induced hyperactivity. Pharmacol Biochem Behav 53: 123-131.
4. Andrade P, Fernandez-Guasti A, Carrillo-Ruiz JD, Ulloa RE, Ramirez Y, Reyes R, et al,. (2009). Effects of bilateral lesions in thalamic reticular nucleus and orbitofrontal cortex in a T-maze perseverative model produced by 8-OH-DPAT in rats. Behav Brain Res 203: 108-112.
5. Aouizerate B, Cuny E, Martin-Guehl C, Guehl D, Amieva H, Benazzouz A, et al,. (2004). Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 101: 682-686. (Pubitemid 43186430)
6. APA (2000). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC.
7. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW, (2003). Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6: 115-116. (Pubitemid 36182778)
8. Aron AR, Behrens TE, Smith S, Frank MJ, Poldrack RA, (2007). Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J Neurosci 27: 3743-3752. (Pubitemid 46557676)
9. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van De Water J, (2010). Altered T cell responses in children with autism. Brain Behav Immun [Epub ahead of print].
10. Balleine BW, O'doherty JP, (2010). Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 35: 48-69.
11. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM, (2002). Response inhibition deficits in obsessive-compulsive disorder. Psychiatry Res 110: 165-174. (Pubitemid 34607612)
12. Baxter L, (1999). Functional imaging of brain systems mediating obsessive-compulsive disorder. In:, Charney DS, Nestler EJ, Bunney BS, (eds). Neurobiology of Mental Illness. Oxford University Press: Oxford, pp. 534-547.
13. Berlin HA, Hamilton H, Hollander E, (2008). Neurocognition and temperament in pathological gambling. American Psychiatric Association, conference poster. Washington, DC.
14. Berridge KC, Aldridge JW, Houchard KR, Zhuang X, (2005). Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol 3: 4.
15. Bienvenu OJ, Wang Y, Shugart YY, Welch JM, Grados MA, Fyer AJ, et al,. (2009). Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet 150B: 710-720.
16. Black DW, Monahan P, Gable J, Blum N, Clancy G, Baker P, (1998). Hoarding and treatment response in 38 nondepressed subjects with Obsessive-Compulsive Disorder. J Clin Psychiatry 59: 420-425. (Pubitemid 28391564)
17. Blier P, De Montigny C, (1998). Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol Psychiatry 44: 313-323. (Pubitemid 28432642)
18. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF, (2006). A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11: 622-632. (Pubitemid 43989810)
19. Bloch MH, Craiglow BG, Landeros-Weisenberger A, Dombrowski PA, Panza KE, Peterson BS, et al,. (2009). Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics 124: 1085-1093.
20. Bolton D, Luckie M, Steinberg D, (1995). Long-term course of obsessive-compulsive disorder treated in adolescence. J Am Acad Child Adolesc Psychiatry 34: 1441-1450.
21. Boulougouris V, Robbins TW, (2010). Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. J Neurosci 30: 930-938.
22. Boulougouris V, Dalley JW, Robbins TW, (2007). Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res 179: 219-228. (Pubitemid 46497457)
23. Boulougouris V, Glennon JC, Robbins TW, (2008). Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology 33: 2007-2019. (Pubitemid 351832598)
24. Boulougouris V, Chamberlain SR, Robbins TW, (2009). Cross-species models of OCD spectrum disorders. Psychiatry Res 170: 15-21.
25. Brown SA, Crowell-Davis S, Malcolm T, Edwards P, (1987). Naloxone-responsive compulsive tail chasing in a dog. J Am Vet Med Assoc 190: 884-886.
26. Campbell KM, De Lecea L, Severynse DM, Caron MG, Mcgrath MJ, Sparber SB, et al,. (1999a). OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. J Neurosci 19: 5044-5053. (Pubitemid 29270139)
27. Campbell KM, Mcgrath MJ, Burton FH, (1999b). Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion. Brain Res 833: 216-224. (Pubitemid 29333796)
28. Campbell KM, Mcgrath MJ, Burton FH, (1999c). Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists. Eur J Pharmacol 371: 103-111. (Pubitemid 29216992)
29. Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L, (2002). Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 114: 347-353. (Pubitemid 34262689)
30. Cavedini P, Ferri S, Scarone S, Bellodi L, (1998). Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study. Psychiatry Res 78: 21-28. (Pubitemid 28157008)
31. Ceaser AE, Goldberg TE, Egan MF, Mcmahon RP, Weinberger DR, Gold JM, (2008). Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biol Psychiatry 64: 782-788.
32. Chamberlain SR, Menzies L, (2009). Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. Expert Rev Neurother 9: 1133-1146.
33. Chamberlain SR, Sahakian BJ, (2007). The neuropsychiatry of impulsivity. Curr Opin Psychiatry 20: 255-261. (Pubitemid 46588298)
34. Chamberlain SR, Blackwell AD, Fineberg N, Robbins TW, Sahakian BJ, (2005). The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 29: 399-419. (Pubitemid 40488206)
35. Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ, (2006). Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 163: 1282-1284. (Pubitemid 44464460)
36. Chamberlain SR, Del Campo N, Dowson J, Müller U, Clark L, Robbins TW, et al,. (2007a). Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62: 977-984. (Pubitemid 47562368)
37. Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, et al,. (2007b). Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry 164: 335-338.
38. Chamberlain SR, Menzies L, Sahakian BJ, Fineberg NA, (2007c). Lifting the veil on Trichotillomania. Am J Psychiatry 164: 568-574. (Pubitemid 46650186)
39. Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, Del Campo N, et al,. (2008). Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 321: 421-422. (Pubitemid 352029981)
40. Chamberlain SR, Odlaug BL, Boulougouris V, Fineberg NA, Grant JE, (2009). Trichotillomania: neurobiology and treatment. Neurosci Biobehav Rev 33: 831-842.
41. Chen SK, Tvrdik P, Peden E, Cho S, Wu S, Spangrude G, et al,. (2010). Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141: 775-785.
42. Chou-Green JM, Holscher TD, Dallman MF, Akana SF, (2003). Compulsive behavior in the 5-HT2C receptor knockout mouse. Physiol Behav 78: 641-649. (Pubitemid 36628092)
43. Chudasama Y, Robbins TW, (2003). Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex. J Neurosci 23: 8771-8780. (Pubitemid 37176658)
44. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC, (2004). Cognitive inflexibility after prefrontal serotonin depletion. Science 304: 878-880. (Pubitemid 38620188)
45. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC, (2005). Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 25: 532-538. (Pubitemid 40105626)
46. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC, (2007). Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb Cortex 17: 18-27. (Pubitemid 44973891)
47. Clarke HF, Robbins TW, Roberts AC, (2008). Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 28: 10972-10982.
48. Corbit LH, Balleine BW, (2003). The role of prelimbic cortex in instrumental conditioning. Behav Brain Res 146: 145-157. (Pubitemid 37476141)
49. Coutureau E, Killcross S, (2003). Inactivation of the infralimbic prefrontal cortex reinstates goal-directed responding in overtrained rats. Behav Brain Res 146: 167-174. (Pubitemid 37476143)
50. Creese I, Iversen SD, (1975). The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83: 419-436.
51. De Wit S, Corlett PR, Aitken MR, Dickinson A, Fletcher PC, (2009). Differential engagement of the ventromedial prefrontal cortex by goal-directed and habitual behavior toward food pictures in humans. J Neurosci 29: 11330-11338.
52. Denys D, Klompmakers AA, Westenberg HG, (2004a). Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology (Berl) 176: 195-203. (Pubitemid 39517949)
53. Denys D, Van Der Wee N, Janssen J, De Geus F, Westenberg HG, (2004b). Low level of dopaminergic D(2) receptor binding in obsessive-compulsive disorder. Biol Psychiatry 55: 1041-1045. (Pubitemid 38581920)
54. Denys D, Mantione M, Figee M, Van Den Munckhof P, Koerselman F, Westenberg H, et al,. (2010). Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 67: 1061-1068.
55. Devito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, et al,. (2009). Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) 202: 531-539.
56. Dias R, Robbins TW, Roberts AC, (1996). Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380: 69-72. (Pubitemid 26076238)
57. Dias-Ferreira E, Sousa JC, Melo I, Morgado P, Mesquita AR, Cerqueira JJ, et al,. (2009). Chronic stress causes frontostriatal reorganization and affects decision-making. Science 325: 621-625.
58. Djodari-Irani A, Klein J, Banzhaf J, Joel D, Heinz A, Harnack D, et al,. (2011). Activity modulation of the globus pallidus and the nucleus entopeduncularis affects compulsive checking in rats. Behav Brain Res 219: 149-158.
59. Drummond LM, Fineberg NA, (2007). Obsessive-compulsive disorders. In:, Stein G, (ed.). College Seminars in Adult Psychiatry. Gaskell: London, pp. 270-286.
60. Eagle DM, Robbins TW, (2003). Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117: 1302-1317. (Pubitemid 37549431)
61. Eagle DM, Tufft MR, Goodchild HL, Robbins TW, (2007). Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192: 193-206. (Pubitemid 46669203)
62. Enright SJ, Beech AR, (1993). Reduced cognitive inhibition in obsessive-compulsive disorder. Br J Clin Psychol 32 (Pt 1): 67-74. (Pubitemid 23087723)
63. Everitt BJ, Robbins TW, (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489. (Pubitemid 41573659)
64. Fineberg NA, Gale TM, (2005). Evidence-based pharmacotherapy of obsessivecompulsive disorder. Int J Neuropsychopharmacol 8: 107-129.
65. Fineberg NA, Fourie H, Gale TM, Sivakumaran T, (2005a). Comorbid depression in obsessive compulsive disorder (OCD): symptomatic differences to major depressive disorder. J Affect Disord 87: 327-330. (Pubitemid 41039956)
66. Fineberg NA, Sivakumaran T, Roberts A, Gale T, (2005b). Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Int Clin Psychopharmacol 20: 223-226. (Pubitemid 40896377)
67. Fineberg NA, Gale TM, Sivakumaran T, (2006a). A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol 20: 97-103.
68. Fineberg NA, Nigam A, Silvakumaran T, (2006b). Pharmacological strategies for treatment-resistant obsessive compulsive disorder. Psychiatr Ann 36: 464-474.
69. Fineberg NA, Stein DJ, Premkumar P, Carey P, Sivakumaran T, Vythilingum B, et al,. (2006c). Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials. Int Clin Psychopharmacol 21: 337-343. (Pubitemid 44498275)
70. Fineberg NA, Sharma P, Sivakumaran T, Sahakian B, Chamberlain SR, (2007). Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum? CNS Spectr 12: 467-482.
71. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, et al,. (2010). Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 35: 591-604.
72. Flaisher-Grinberg S, Klavir O, Joel D, (2008). The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder. Int J Neuropsychopharmacol 11: 811-825.
73. Garner JP, Dufour B, Gregg LE, Weisker SM, Mench JA, (2004a). Social and husbandry factors affecting the prevalence and severity of barbering ('whisker trimming') by laboratory mice. Appl Anim Behav Sci 89: 263-282. (Pubitemid 39415548)
74. Garner JP, Weisker SM, Dufour B, Mench JA, (2004b). Barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders. Comp Med 54: 216-224. (Pubitemid 38590839)
75. Geyer MA, Markou A, (1995). Animal models of psychiatric disorders. In:, Bloom FE, Kupfer DJ, (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, pp. 787-798.
76. Geyer MA, Markou A, (2002). The role of preclinical models in the development of psychotropic drugs. In:, Davis KL, Coyle JT, Nemeroff C, (eds). Psychopharmacology: the Fifth Generation of Progress. LWW: Hagerstown, MD, USA, pp. 445-455.
77. Gillan CM, Butt M, Morein-Zamir S, Sahakian BJ, Fineberg NA, Robbins TW, et al,. (2010). Disrupted balance between goal-directed behavior versus habit learning in obsessive-compulsive disorder. Am J Psychiatry (in press).
78. Graf M, (2006). 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder. Neuropsychopharmacol Hung 8: 23-28.
79. Grant JE, Odlaug BL, Kim SW, (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 66: 756-763.
80. Graybiel AM, (1997). The basal ganglia and cognitive pattern generators. Schizophr Bull 23: 459-469. (Pubitemid 27427985)
81. Graybiel AM, Rauch SL, (2000). Toward a neurobiology of obsessive-compulsive disorder. Neuron 28: 343-347.
82. Greenberg BD, Gabriels LA, Malone DA, Jr, Rezai AR, Friehs GM, Okun MS, et al,. (2008). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry 15: 64-79.
83. Greenberg BD, Rauch SL, Haber SN, (2010). Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 35: 317-336.
84. Greer JM, Capecchi MR, (2002). Hoxb8 is required for normal grooming behavior in mice. Neuron 33: 23-34. (Pubitemid 34088176)
85. Grindlinger HM, Ramsay E, (1991). Compulsive feather picking in birds. Arch Gen Psychiatry 48: 857.
86. Hamon M, Boer PA, Mocaer E, (2005). New perspectives in the pathophysiology and treatment of affective disorders: the role of melatonin and serotonin. Medicographia 27: 228-235.
87. Hampshire A, Owen AM, (2006). Fractionating attentional control using event-related fMRI. Cereb Cortex 16: 1679-1689. (Pubitemid 44729906)
88. Hampshire A, Chamberlain SR, Monti MM, Duncan J, Owen AM, (2010). The role of the right inferior frontal gyrus: inhibition and attentional control. Neuroimage 50: 1313-1319.
89. Hanna GL, (1995). Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 34: 19-27.
90. Hanna GL, Veenstra-Vanderweele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, et al,. (2002). Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 114: 541-552. (Pubitemid 34680583)
91. Hanna GL, Veenstra-Vanderweele J, Cox NJ, Van Etten M, Fischer DJ, Himle JA, et al,. (2007). Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biol Psychiatry 62: 856-862. (Pubitemid 47488218)
92. Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, et al,. (2000). Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry 57: 76-82. (Pubitemid 30035662)
93. Hollander E, (2008). Obsessive-compulsive spectrum phenomena and the DSM-V developmental process. CNS Spectr 13: 107-108.
94. Hollander E, Rosen J, (2000). Impulsivity. J Psychopharmacol 14: S39-S44. (Pubitemid 30389500)
95. Hollander E, Wong CM, (1995). Obsessive-compulsive spectrum disorders. J Clin Psychiatry 56 (Suppl 4): 3-6; discussion 53-5.
96. Hollander E, Decaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, et al,. (1991). Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Res 36: 1-17.
97. Hollander E, Braun A, Simeon D, (2008). Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety 25: 317-329. (Pubitemid 351614566)
98. Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M, (2010). Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. J Clin Psychiatry 71: 784-792.
99. Hoshino K, Uga DA, De Paula HM, (2004). The compulsive-like aspect of the head dipping emission in rats with chronic electrolytic lesion in the area of the median raphe nucleus. Braz J Med Biol Res 37: 245-250. (Pubitemid 38268157)
100. Hranov G, Fineberg NA, (2010). Are tics an essential symptom of the obsessive compulsive syndrome? Eur Neuropsychopharmacol 20: s521.
101. Ichimaru Y, Egawa T, Sawa A, (1995). 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 68: 65-70.
102. Insel TR, Hamilton JA, Guttmacher LB, Murphy DL, (1983). d-amphetamine in obsessive-compulsive disorder. Psychopharmacology (Berl) 80: 231-235. (Pubitemid 13078839)
103. Jefferies K, Laws K, Fineberg NA, (2010). Cognitive and perceptual processing in body dysmorphic disorder. Eur Neuropsychopharmacol 20: s309.
104. Joel D, Avisar A, (2001). Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder? Behav Brain Res 123: 77-87. (Pubitemid 32506825)
105. Joel D, Ben-Amir E, Doljansky J, Flaisher S, (2004). 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam. Behav Pharmacol 15: 241-252. (Pubitemid 38859607)
106. Joffe RT, Swinson RP, Levitt AJ, (1991). Acute psychostimulant challenge in primary obsessive-compulsive disorder. J Clin Psychopharmacol 11: 237-241.
107. Jog MS, Kubota Y, Connolly CI, Hillegaart V, Graybiel AM, (1999). Building neural representations of habits. Science 286: 1745-1749. (Pubitemid 129515883)
108. Katerberg H, Delucchi KL, Stewart SE, Lochner C, Denys DA, Stack DE, et al,. (2010). Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet 40: 505-517.
109. Killcross S, Coutureau E, (2003). Coordination of actions and habits in the medial prefrontal cortex of rats. Cereb Cortex 13: 400-408. (Pubitemid 36373685)
110. Kim H, Shimojo S, O'doherty JP, (2006). Is avoiding an aversive outcome rewarding? Neural substrates of avoidance learning in the human brain. PLoS Biol 4: e233.
111. Klavir O, Flash S, Winter C, Joel D, (2009). High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces 'compulsive' lever-pressing in rats. Exp Neurol 215: 101-109.
112. Kolevzon A, Mathewson KA, Hollander E, (2006). Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 67: 407-414.
113. Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, et al,. (2009). Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry 66: 1233-1241.
114. Lapiz MD, Morilak DA, (2006). Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137: 1039-1049. (Pubitemid 43053965)
115. Lapiz-Bluhm MD, Soto-Pina AE, Hensler JG, Morilak DA, (2009). Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl) 202: 329-341.
116. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al,. (1997). Symptoms of obsessive-compulsive disorder. Am J Psychiatry 154: 911-917. (Pubitemid 27274532)
117. Leckman JF, Pauls DL, Zhang H, Rosario-Campos MC, Katsovich L, Kidd KK, et al,. (2003). Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 116B: 60-68. (Pubitemid 37063616)
118. Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, et al,. (2010). Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety 27: 507-527.
119. Leonard HL, Swedo SE, (2001). Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol 4: 191-198. (Pubitemid 32587387)
120. Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA, et al,. (2004a). Corrigendum to 'gender in obsessive-compulsive disorder: clinical and genetic findings'[Eur. Neuropsychopharmacol. 14 (2004) 105-113]. Eur Neuropsychopharmacol 14: 437-445.
121. Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA, et al,. (2004b). Gender in obsessive-compulsive disorder: clinical and genetic findings. Eur Neuropsychopharmacol 14: 105-113. (Pubitemid 38175427)
122. Logan GD, Cowan WB, Davis KA, (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10: 276-291.
123. Lucey JV, Butcher G, Clare AW, Dinan TG, (1993). Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic supersensitivity. Am J Psychiatry 150: 961-962. (Pubitemid 23156781)
124. Luescher UA, Mckeown DB, Dean H, (1998). A cross-sectional study on compulsive behaviour (stable vices) in horses. Equine Vet J Suppl 27: 14-18.
125. Lyon M, Robbins TW, (1975). The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In:, Essman W, Valzelli L, (eds). Current Developments in Psychopharmacology. Spectrum: New York, pp. 80-163.
126. Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, et al,. (2008). Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 359: 2121-2134.
127. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L, (1999). Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 156: 1409-1416. (Pubitemid 29416539)
128. Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L, (2002). Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 71: 255-262. (Pubitemid 35007649)
129. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML, (2004). Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 61: 564-576. (Pubitemid 38747311)
130. Mataix-Cols D, Rosario-Campos MC, Leckman JF, (2005). A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 162: 228-238. (Pubitemid 40216199)
131. Matthysse S, (1986). Animal models in psychiatric research. Prog Brain Res 65: 259-270. (Pubitemid 17150944)
132. Mcgrath MJ, Campbell KM, Veldman MB, Burton FH, (1999). Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior. Behav Pharmacol 10: 435-443. (Pubitemid 29440551)
133. Mcgrath MJ, Campbell KM, Parks CR, Burton FH, (2000). Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder. Brain Res 877: 23-30.
134. Mckinney WT, (2000). Animal research and its relevance to psychiatry. In:, Sadock BJ, Sadock VA, (eds). Kaplan & Sadock's Comprehensive Textbook of Psychiatry. LWW: Baltimore, MD, USA, pp. 545-563.
135. Mckinney WT Jr, Bunney WE Jr, (1969). Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 21: 240-248.
136. Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, Del Campo N, et al,. (2007). Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 130: 3223-3236. (Pubitemid 350209066)
137. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET, (2008). Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32: 525-549. (Pubitemid 351173336)
138. Meyer V, (1966). Modification of expectations in cases with obsessional rituals. Behav Res Ther 4: 273-280.
139. Millan MJ, Girardon S, Mullot J, Brocco M, Dekeyne A, (2002). Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists. Neuropharmacology 42: 677-684. (Pubitemid 34457749)
140. Mossner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, et al,. (2006). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 9: 437-442. (Pubitemid 43979703)
141. Mundt A, Klein J, Joel D, Heinz A, Djodari-Irani A, Harnack D, et al,. (2009). High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 29: 2401-2412.
142. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, et al,. (2005). A functional MRI comparison of patients with obsessive-compulsive disorder and normal controls during a Chinese character Stroop task. Psychiatry Res 139: 101-114. (Pubitemid 40910182)
143. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K, et al,. (2009). Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137: 1235-1246.
144. Nelson A, Killcross S, (2006). Amphetamine exposure enhances habit formation. J Neurosci 26: 3805-3812.
145. Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, et al,. (2006). High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. J Clin Psychiatry 67: 15-22. (Pubitemid 43213277)
146. Nordstrom EJ, Burton FH, (2002). A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 7: 617-625, 524.
147. Nurnberg HG, Keith SJ, Paxton DM, (1997). Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders. Biol Psychiatry 41: 226-229. (Pubitemid 27062664)
148. Padhi A, Mehdi AM, Craig K, Fineberg NA, (2010). Current classification of impulse control disorders: cognitive versus behavioural impulsivity and the role of personality. In:, Potenza MN, Grant JE, (eds). Oxford Handbook of Impulse Control Disorders. Oxford University Press: Oxford (in press).
149. Pampaloni I, Sivakumaran T, Hawley CJ, Al Allaq A, Farrow J, Nelson S, et al,. (2010). High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey. J Psychopharmacol 24: 1439-1445.
150. Pantelis C, Barber FZ, Barnes TR, Nelson HE, Owen AM, Robbins TW, (1999). Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37: 251-270. (Pubitemid 29298095)
151. Patel DD, Laws KR, Padhi A, Farrow JM, Mukhopadhaya K, Krishnaiah R, et al,. (2010). The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis. Psychol Med 40: 921-933.
152. Peris TS, Bergman RL, Asarnow JR, Langley A, Mccracken JT, Piacentini J, (2010). Clinical and cognitive correlates of depressive symptoms among youth with obsessive compulsive disorder. J Clin Child Adolesc Psychol 39: 616-626.
153. Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, et al,. (2010). Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 27: 528-555.
154. Pooley EC, Fineberg N, Harrison PJ, (2007). The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol Psychiatry 12: 556-561. (Pubitemid 46816769)
155. Rachman S, Hodgson R, (1980). Obsessions and Compulsions. Prentice Hall: New York.
156. Rapoport JL, Ryland DH, Kriete M, (1992). Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. Arch Gen Psychiatry 49: 517-521.
157. Rescorla RA, (2001). Retraining of extinguished Pavlovian stimuli. J Exp Psychol Anim Behav Process 27: 115-124. (Pubitemid 33776712)
158. Robbins TW, (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
159. Robbins TW, (2005). Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493: 140-146. (Pubitemid 41636196)
160. Robbins TW, Koob GF, (1980). Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system. Nature 285: 409-412. (Pubitemid 10047223)
161. Robbins TW, Sahakian BJ, (1983). Behavioural effects of psychomotor stimulant drugs: clinical and neuropsychological implications. In:, CREESE I, (ed.). Stimulants, Neurochemical, Behavioural and Clinical Perspectives. Raven Press: New York, pp. 301-338.
162. Roberts AC, Tomic DL, Parkinson CH, Roeling TA, Cutter DJ, Robbins TW, et al,. (2007). Forebrain connectivity of the prefrontal cortex in the marmoset monkey (Callithrix jacchus): an anterograde and retrograde tract-tracing study. J Comp Neurol 502: 86-112. (Pubitemid 46486633)
163. Robinson ES, Dalley JW, Theobald DE, Glennon JC, Pezze MA, Murphy ER, et al,. (2008a). Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 33: 2398-2406.
164. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, et al,. (2008b). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33: 1028-1037. (Pubitemid 351367544)
165. Rosenberg DR, Dick EL, O'hearn KM, Sweeney JA, (1997). Response-inhibition deficits in obsessive-compulsive disorder: an indicator of dysfunction in frontostriatal circuits. J Psychiatry Neurosci 22: 29-38. (Pubitemid 127489626)
166. Sahakian BJ, Robbins TW, (1975). The effects of test environment and rearing condition on amphetamine-induced stereotypy in the guinea-pig. Psychopharmacologia 45: s115-s117.
167. Samuels J, Bienvenu OJ, Riddle MA, Cullen BA, Grados MA, Liang KY, et al,. (2002). Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther 40: 517-528. (Pubitemid 34270463)
168. Schilman EA, Uylings HB, Galis-De Graaf Y, Joel D, Groenewegen HJ, (2008). The orbital cortex in rats topographically projects to central parts of the caudate-putamen complex. Neurosci Lett 432: 40-45.
169. Shmelkov SV, Hormigo A, Jing D, Proenca CC, Bath KG, Milde T, et al,. (2010). Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 16: 598-602, 1p following 602.
170. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, et al,. (2006). Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11: 763-770. (Pubitemid 44141809)
171. Skoog G, Skoog I, (1999). A 40-year follow-up of patients with obsessive-compulsive disorder [see comments]. Arch Gen Psychiatry 56: 121-127. (Pubitemid 29081385)
172. Solomon RL, Kamin LJ, Wynne LC, (1953). Traumatic avoidance learning: the outcomes of several extinction procedures with dogs. J Abnorm Psychol 48: 291-302.
173. Sprengelmeyer R, Young AW, Pundt I, Sprengelmeyer A, Calder AJ, Berrios G, et al,. (1997). Disgust implicated in obsessive-compulsive disorder. Proc R Soc Lond B Biol Sci 264: 1767-1773. (Pubitemid 28021587)
174. Stein DJ, Dodman NH, Borchelt P, Hollander E, (1994). Behavioral disorders in veterinary practice: relevance to psychiatry. Compr Psychiatry 35: 275-285. (Pubitemid 24214815)
175. Summerfeldt LJ, Richter MA, Antony MM, Swinson RP, (1999). Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther 37: 297-311. (Pubitemid 29119225)
176. Swanepoel N, Lee E, Stein DJ, (1998). Psychogenic alopecia in a cat: response to clomipramine. J S Afr Vet Assoc 69: 22. (Pubitemid 28325869)
177. Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL, (1989). A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 321: 497-501. (Pubitemid 19203873)
178. Szechtman H, Woody E, (2004). Obsessive-compulsive disorder as a disturbance of security motivation. Psychol Rev 111: 111-127. (Pubitemid 38157078)
179. Szechtman H, Sulis W, Eilam D, (1998). Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci 112: 1475-1485. (Pubitemid 29052635)
180. Tanaka SC, Balleine BW, O'doherty JP, (2008). Calculating consequences: brain systems that encode the causal effects of actions. J Neurosci 28: 6750-6755.
181. Tardito D, Milanese M, Bonifacino T, Musazzi L, Grilli M, Mallei A, et al,. (2010). Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways. BMC Neurosci 11: 68.
182. Tien AY, Pearlson GD, Machlin SR, Bylsma FW, Hoehn-Saric R, (1992). Oculomotor performance in obsessive-compulsive disorder. Am J Psychiatry 149: 641-646.
183. Tricomi E, Balleine BW, O'doherty JP, (2009). A specific role for posterior dorsolateral striatum in human habit learning. Eur J Neurosci 29: 2225-2232.
184. Tricomi EM, Delgado MR, Fiez JA, (2004). Modulation of caudate activity by action contingency. Neuron 41: 281-292. (Pubitemid 38125188)
185. Tsaltas E, Kontis D, Chrysikakou S, Giannou H, Biba A, Pallidi S, et al,. (2005). Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology. Biol Psychiatry 57: 1176-1185. (Pubitemid 40615780)
186. Valentin VV, Dickinson A, O'doherty JP, (2007). Determining the neural substrates of goal-directed learning in the human brain. J Neurosci 27: 4019-4026. (Pubitemid 46597159)
187. Van Den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, et al,. (2005). Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry 62: 922-933. (Pubitemid 41126887)
188. Vertes RP, (2004). Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51: 32-58. (Pubitemid 37421138)
189. Walker SC, Robbins TW, Roberts AC, (2009). Differential contributions of dopamine and serotonin to orbitofrontal cortex function in the marmoset. Cereb Cortex 19: 889-898.
190. Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, et al,. (2007). Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448: 894-900. (Pubitemid 47312780)
191. Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, et al,. (2009). A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry 66: 408-416.
192. Westenberg HG, Fineberg NA, Denys D, (2007). Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 12: 14-27.
193. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS, (2006). A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 146: 137-147.
194. Willner P, (1984). The validity of animal models of depression. Psychopharmacology (Berl) 83: 1-16. (Pubitemid 14141479)
195. Willner P, (1991). Behavioural models in psychopharmacology. In:, Willner P, (ed.). Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. Cambridge University Press: Cambridge, pp. 3-18.
196. Winsberg ME, Cassic KS, Koran LM, (1999). Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry 60: 591-597. (Pubitemid 29451555)
197. Winslow JT, Insel TR, (1991). Neuroethological models of obsessive-compulsive disorder. In:, Zohar J, Insel TR, Rasmussen S, (eds). The Psychobiology of Obsessive-Compulsive Disorder. Springer: New York, pp. 179-182.
198. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW, (2004). 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176: 376-385. (Pubitemid 40012745)
199. Wolinsky TD, Smith DG, Nugent B, Antonijevic I, Moore N, (2006). Potentiation of SSRI efficacy by neurokinin 1 receptor antagonism. Int J Neuropsychopharmacol 9: s114.
200. Woods A, Smith C, Szewczak M, Dunn RW, Cornfeldt M, Corbett R, (1993). Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology (Berl) 112: 195-198. (Pubitemid 23278278)
201. Yadin E, Friedman E, Bridger WH, (1991). Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder? Pharmacol Biochem Behav 40: 311-315.
202. Yin HH, Knowlton BJ, (2006). The role of the basal ganglia in habit formation. Nat Rev Neurosci 7: 464-476. (Pubitemid 44012286)
203. Yin HH, Knowlton BJ, Balleine BW, (2004). Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci 19: 181-189. (Pubitemid 38122084)
204. Yin HH, Ostlund SB, Knowlton BJ, Balleine BW, (2005). The role of the dorsomedial striatum in instrumental conditioning. Eur J Neurosci 22: 513-523. (Pubitemid 41097624)
205. Zohar AH, (1999). The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 8: 445-460. (Pubitemid 29360203)
206. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL, (1988). Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. Arch Gen Psychiatry 45: 167-172. (Pubitemid 18052849)
207. Zohar J, Kennedy JL, Hollander E, Koran LM, (2004). Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. J Clin Psychiatry 65 (Suppl. 14): 18-21.
208. Zor R, Fineberg NA, Hermesh H, Eilam D, (2010). A video telemetry documentation of OCD behavior: Studying cultural impact on OC behavior and the validity of OCD sub-typing. Poster presented at the Annual Meeting of the International College of Obsessive-Compulsive Spectrum Disorders, Amsterdam, ND. September 2nd, 2010.
209. Zuchner S, Cuccaro ML, Tran-Viet KN, Cope H, Krishnan RR, Pericak-Vance MA, et al,. (2006). SLITRK1 mutations in trichotillomania. Mol Psychiatry 11: 887. (Pubitemid 44470209)